[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Diaz et al., 2010 - Google Patents

Male sexual dysfunction

Diaz et al., 2010

Document ID
9083405508055782924
Author
Diaz V
Close J
Publication year
Publication venue
Primary Care: Clinics in Office Practice

External Links

Snippet

Premature ejaculation (PE) is the most common type of male sexual dysfunction. Most clinicians use the broad definition of PE as ejaculation occurring sooner than desired (before or shortly after penetration), causing distress to one or both partners. No strict time …
Continue reading at www.primarycare.theclinics.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epihephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids

Similar Documents

Publication Publication Date Title
Simon et al. Sexual well-being after menopause: an international menopause society white paper
Nguyen et al. Erectile dysfunction in young men—a review of the prevalence and risk factors
Shamloul et al. Erectile dysfunction
Clayton Sexual function and dysfunction in women
Montague et al. Chapter 1: The management of erectile dysfunction: an AUA update
Krakowsky et al. A practical guide to female sexual dysfunction: An evidence-based review for physicians in Canada
Heidelbaugh Management of erectile dysfunction
Ludwig et al. Organic causes of erectile dysfunction in men under 40
Guay et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of male sexual dysfunction: a couple’s problem–2003 update
McMahon et al. Standard operating procedures in the disorders of orgasm and ejaculation
Jannini et al. Ejaculatory disorders: epidemiology and current approaches to definition, classification and subtyping
Klein et al. Continuing medical education: sexual functioning in transsexuals following hormone therapy and genital surgery: a review (CME)
Hackett et al. British Society for Sexual Medicine guidelines on the management of erectile dysfunction
Mohee et al. Medical therapy for premature ejaculation
Krychman et al. Sexual oncology: sexual health issues in women with cancer
Steiner et al. Advances in the diagnosis and treatment of premenstrual dysphoria
Diaz et al. Male sexual dysfunction
Sartor et al. Health-related quality of life in advanced prostate cancer and its treatments: biochemical failure and metastatic disease populations
Shin et al. The evaluation and treatment of delayed ejaculation
Oh et al. Testosterone replacement in men with sexual dysfunction
Gueldini de Moraes et al. Medication use and sexual function: a population-based study in middle aged women
Grunvald Medical management of obesity: a comprehensive review
Narang et al. Psychosexual disorders and dermatologists
Basson Pharmacotherapy for women's sexual dysfunction
Kammerer-Doak et al. Female sexual dysfunction